Moreover, substantial evidence demonstrates that in hormone-dependent breast cancer cells, ERα binding to PPRE elements represses PPARγ transactivation, implying that a functional crosstalk between the two receptors affects breast cancer progression [18]. This evidence concerns the gene ESR1 and breast carcinoma.